A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell non-Hodgkin Lymphoma (Glo-BNHL)

The Glo-BNHL trial is the largest platform trial in paediatric and adolescent relapsed and refractory B-cell malignancies globally. 

How platform trials are improving childhood cancer treatment | University of Birmingham

News

Woman standing and talking to a group

Explore the latest trial news and publications

Also in 'Glo-BNHL'